hydromorphone and dezocine

hydromorphone has been researched along with dezocine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Bigelow, GE; Liebson, IA; Preston, KL; Strain, EC1
Chen, J; Du, Z; Duan, G; Li, H; Liao, W; Peng, J; Yan, G; Yang, G; Yu, Z1

Trials

2 trial(s) available for hydromorphone and dezocine

ArticleYear
Opioid antagonist effects of dezocine in opioid-dependent humans.
    Clinical pharmacology and therapeutics, 1996, Volume: 60, Issue:2

    Topics: Adult; Bridged Bicyclo Compounds, Heterocyclic; Cognition; Cycloparaffins; Humans; Hydromorphone; Male; Monitoring, Physiologic; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Psychomotor Performance; Surveys and Questionnaires; Tetrahydronaphthalenes

1996
Effects of patient-controlled analgesia with hydromorphone or sufentanil on postoperative pulmonary complications in patients undergoing thoracic surgery: a quasi-experimental study.
    BMC anesthesiology, 2018, 12-19, Volume: 18, Issue:1

    Topics: Adult; Analgesia, Patient-Controlled; Benzimidazoles; Blood Gas Analysis; Bridged Bicyclo Compounds, Heterocyclic; Double-Blind Method; Female; Humans; Hydromorphone; Intensive Care Units; Length of Stay; Lung Diseases; Male; Middle Aged; Pain, Postoperative; Postoperative Complications; Sufentanil; Tetrahydronaphthalenes; Thoracic Surgical Procedures

2018

Other Studies

1 other study(ies) available for hydromorphone and dezocine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004